18 completed, 3 not yet recruiting, 3 unknown, 2 recruiting. 10 Not applicable, 6 Phase 2, 3 Phase 1, 2 Phase 4.
Follow End-stage Renal Disease (ESRD): new trials by email Literature Review of End-stage Renal Disease (ESRD) trials Research Report on End-stage Renal Disease (ESRD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Microbiota Changes Related to Outcomes in Kidney Transplantation Fecal samples, Urinary sample, Blood samples - End-stage Renal Disease (ESRD), Kidney Transplantation | Not yet recruiting | Hospices Civils de Lyon | 30 | 2027-01-01 | 2026-10-26 | |
| Anakinra for the Treatment of Postprandial Hypoglycemia in a Patient With Total Gastrectomy and End-Stage Renal Disease Anakinra (interleukin-1 receptor antagonist), Placebo Comparator (0.9% NaCl) - Postprandial Hypoglycemia, End-stage Renal Disease (ESRD) | Phase 2 | Not yet recruiting | Marc Donath | 1 | 2026-07-01 | 2026-05-12 |
| Pilot Trial of Oral Sodium Bicarbonate Versus Higher Dialysate Bicarbonate in Hemodialysis Patients With Metabolic Acidosis Oral sodium bicarbonate, Increased Dialysate Bicarbonate - End-stage Renal Disease (ESRD), Chronic Hemodialysis | Not applicable | Not yet recruiting | University of Sfax | 37 | 2026-07-01 | 2026-07-21 |
| Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients amino acid (15) peritoneal dialysis solution - End-stage Renal Disease (ESRD), Peritoneal Dialysis (PD) | Phase 4 | Enrolling by invitation | Shanghai 10th People's Hospital | 50 | 2026-05-01 | 2026-04-28 |
| Clinical Observation of Renal Function Reactivation Following a GRAS-Based Protocol in Patients With Chronic Kidney Disease and Long-Term Renal Arrest. CSR-CKD Oral Protocol - End-Stage Renal Disease (ESRD) Chronic Kidney Disease, Stage 5 Renal Regeneration Anuria Diabetic Nephropathy, Anuria | Completed | Amar h Zireg | 8 | 2026-02-02 | 2026-05-27 | |
| Effect of Intradialytic Eating Timing on Hemodynamic Stability and Dialysis Adequacy in Hemodialysis Patients Intradialytic Eating Timing Intervention - Chronic Kidney Disease, End-stage Renal Disease (ESRD) | Not applicable | Completed | Universitas Muhammadiyah Surakarta | 40 | 2026-01-22 | 2026-03-11 |
| Exercise Rehabilitation for Functional Impairment in Maintenance Hemodialysis Patients Exercise Rehabilitation Therapy (ERT) - End-Stage Renal Disease (ESRD), Maintenance Hemodialysis (MHD) | Not applicable | Active not recruiting | The First People's Hospital of Yunnan | 60 | 2025-06-01 | 2026-02-10 |
| A Comparative Study of Intradialytic vs. Pre-Dialysis Physical Therapy Interventions in Individuals Undergoing Hemodialysis: A Randomized Controlled Trial Physical Therapy Exercise Program - End-stage Renal Disease (ESRD), Chronic Kidney Disease | Not applicable | Recruiting | Mohammad Arian | 72 | 2025-03-02 | 2026-01-22 |
| Epidemiology And Risk Factors Of Intradialytic Hypotension In Maintenance Hemodialysis Patients Intradialytic Hypotension, End-stage Renal Disease (ESRD) | Completed | First Affiliated Hospital of Wannan Medical College | 395 | 2025-02-15 | 2026-04-22 | |
| A Study of Avacopan in Participants With Normal Renal Function and Participants With End-Stage Renal Disease (ESRD) Avacopan - End-Stage Renal Disease (ESRD) | Phase 1 | Completed | Amgen | 13 | 2024-06-18 | 2026-09-11 |
| NIRS for the Diagnosis of Residual Renal Function Injury in Hemodialysis Patients End-stage Renal Disease (ESRD) | Unknown | Yuanjun Yang | 30 | 2024-02-15 | 2024-02-06 | |
| Hierarchical Management for Maintenance Hemodialysis Patients Triangle Hierarchical Management, routine care - End-stage Renal Disease (ESRD) | Not applicable | Completed | Yanyan Deng | 80 | 2024-01-01 | 2025-08-14 |
| Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Older Japanese Participants on Dialysis (MK-2060-012) MK-2060, Placebo - End-Stage Renal Disease (ESRD), End-Stage Kidney Disease (ESKD) | Phase 1 | Completed | Merck Sharp & Dohme LLC | 17 | 2023-06-14 | 2025-03-14 |
| Rheological Functions of Erythrocyte in ESRD Blood collection, Cardiopulmonary exercise testing (CPET) - End-stage Renal Disease (ESRD) | Recruiting | Chang Gung Memorial Hospital | 40 | 2022-08-24 | 2025-03-11 | |
| Oral L-carnitine and Inflammatory and Nutritional Biomarkers in Maintenance Hemodialysis L-carnitine 1000 Mg, Placebo - End-stage Renal Disease (ESRD), Hemodialysis | Phase 2 | Completed | Darya Chamani | 50 | 2020-11-30 | 2025-12-19 |
| Effect of Lifestyle Intervention in Patients With Chronic Kidney Disease on Fitness and Immune Function Cyclic aerobic and resistance training - End-stage Renal Disease (ESRD) | Not applicable | Completed | Chang Gung Memorial Hospital | 34 | 2020-07-01 | 2025-08-19 |
| Creating a Buttonhole Tunnel Track by Repeated Needling of the AV Fistula on the Same Day in Patients on Hemodialysis. Repeated cannulation Buttonhole., Single cannulation Buttonhole. - End-stage Renal Disease (ESRD) | Not applicable | Completed | Esbjerg Hospital - University Hospital of Southern Denmark | 43 | 2019-05-20 | 2025-03-10 |
| A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD) EPN-701 (Oral) - End-Stage Renal Disease (ESRD) | Phase 2 | Completed | Epizon Pharma, Inc. | 18 | 2019-03-01 | 2024-09-25 |
| A Study of ISIS 416858 Administered Subcutaneously to Participants With End-Stage Renal Disease (ESRD) on Hemodialysis ISIS 416858, Placebo - End-stage Renal Disease (ESRD) | Phase 2 | Completed | Ionis Pharmaceuticals, Inc. | 213 | 2017-12-26 | 2023-01-20 |
| Intracellular Phosphate Concentration Evolution During Hemodialysis by MR Spectroscopy Phosphorus (31P) magnetic resonance spectroscopy, Hemodialysis - End-Stage Renal Disease (ESRD) | Not applicable | Completed | Hospices Civils de Lyon | 11 | 2017-06-14 | 2025-12-19 |
Showing 20 of 28. Sign in to see all of them.
Kidney Failure, Chronic (28) · Renal Insufficiency, Chronic (6) · Inflammation (2) · Acidosis (1) · Anemia, Hemolytic, Autoimmune (1) · Anuria (1) · Arteriovenous Fistula (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Dysbiosis (1) · Glucose Metabolism Disorders (1) · Hypoglycemia (1) · Infections (1) · Kidney Diseases (1) · Malnutrition (1)
Chronic Disease (28) · Disease Attributes (28) · Female Urogenital Diseases (28) · Female Urogenital Diseases and Pregnancy Complications (28) · Male Urogenital Diseases (28) · Pathologic Processes (28) · Pathological Conditions, Signs and Symptoms (28) · Renal Insufficiency (28) · Urogenital Diseases (28) · Urologic Diseases (28) · Kidney Diseases (27) · Renal Insufficiency, Chronic (22) · Nutritional and Metabolic Diseases (4) · Metabolic Diseases (3) · Behavior (2)
Blood Specimen Collection (2) · ISIS 416858 (2) · Saline Solution (2) · Amino Acids (1) · Carnitine (1) · Cholecalciferol (1) · Dialysis Solutions (1) · Exercise Test (1) · Exercise Therapy (1) · Icodextrin (1) · Interleukin 1 Receptor Antagonist Protein (1) · Magnetic Resonance Spectroscopy (1) · Receptors, Interleukin-6 (1) · Renal Dialysis (1) · Resistance Training (1)
Chang Gung Memorial Hospital (2) · Hospices Civils de Lyon (2) · Ionis Pharmaceuticals, Inc. (2) · Amar h Zireg (1) · Amgen (1) · Bioverativ, a Sanofi company (1) · Darya Chamani (1) · Epizon Pharma, Inc. (1) · Esbjerg Hospital - University Hospital of Southern Denmark (1) · First Affiliated Hospital of Wannan Medical College (1) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1) · Marc Donath (1) · Merck Sharp & Dohme LLC (1) · Mohammad Arian (1) · National Taiwan University Hospital (1)
China (5) · United States (5) · Canada (3) · Taiwan (3) · France (2) · Algeria (1) · Austria (1) · Denmark (1) · Indonesia (1) · Iran (1) · Italy (1) · Japan (1) · Kuwait (1) · Spain (1) · Switzerland (1)
Ahmed Hakim, MD, Professor (1) · Guangyan Cai, PhD (1) · Jason Stubbs, MD (1) · Kamyar Kalantar-Zadeh, MD, MPH, PhD (1) · Kwan-Dun Wu, MD. PhD (1) · Lobna Ben Mahmoud, MD, PhD, Professor (1) · Marcel Ruzicka, MD, PhD (1) · Mark T Smith, MD (1) · Matthias Hepprich, PD Dr. med. (1) · Mette KM Axelsen, RN,MHS (1) · Richard Yocum, MD (1)
PMID 27716293, PMID 28324018, PMID 28926521, PMID 28980446, PMID 30559259, PMID 33093193, PMID 35155859, PMID 38189593, PMID 38995690, PMID 41126503
2014 (1), 2017 (1), 2025 (1), K24DK091419 (1)